0.59CNY
1.17 BCNY
3.06 BCNY
1.19 B
About TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD.
Sector
CEO
Chun Sheng Leng
Headquarters
Tonghua
Website
Employees (FY)
3.2 K
Founded
1992
ISIN
CNE000000H87
FIGI
BBG000DJDWP1
Tonghua Dongbao Pharmaceutical Co., Ltd. is engaged in the manufacture, distribution, research and development of pharmaceuticals. Its main products include hard capsules, tablets, granules, small volume injections, traditional Chinese medicine, active pharmaceutical ingredients (recombinant human insulin) and bio-engineering products. The company also produces building materials such as plastic steel windows. Tonghua Dongbao Pharmaceutical was founded on December 28, 1992 and is headquartered in Jilin, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 600867 is 10.03 CNY — it has decreased by 1.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. stocks are traded under the ticker 600867.
TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. is going to release the next earnings report on Apr 27, 2024. Keep track of upcoming events with our Earnings Calendar.
600867 stock is 2.42% volatile and has beta coefficient of 0.96. Check out the list of the most volatile stocks — is TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. there?
One year price forecast for TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. has a max estimate of 17.00 CNY and a min estimate of 14.00 CNY.
600867 earnings for the last quarter are 0.14 CNY per share, whereas the estimation was 0.12 CNY resulting in a 16.67% surprise. The estimated earnings for the next quarter are 0.21 CNY per share. See more details about TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. earnings.
TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. revenue for the last quarter amounts to 725.00 M CNY despite the estimated figure of 807.24 M CNY. In the next quarter revenue is expected to reach 1.00 B CNY.
Yes, you can track TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. financials in yearly and quarterly reports right on TradingView.
600867 stock has fallen by 0.69% compared to the previous week, the month change is a 2.81% fall, over the last year TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. has showed a 18.39% decrease.
600867 net income for the last quarter is 407.68 M CNY, while the quarter before that showed 275.35 M CNY of net income which accounts for 48.06% change. Track more TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. financial stats to get the full picture.
Today TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. has the market capitalization of 20.08 B, it has decreased by 4.49% over the last week.
TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. dividend yield was 2.31% in 2023, and payout ratio reached 42.34%. The year before the numbers were 5.45% and 62.29% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 600867 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 3.20 K employees. See our rating of the largest employees — is TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. stock shows the sell signal. See more of TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. future price: according to them, 600867 price has a max estimate of 17.00 CNY and a min estimate of 14.00 CNY. Read a more detailed TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. forecast: see what analysts think of TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. EBITDA is 1.47 B CNY, and current EBITDA margin is 48.27%. See more stats in TONGHUA DONGBAO PHARMACEUTICAL CO.,LTD. financial statements.